HCRN-GU16-260

Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma

Status

Enrollment Closed

Cancer Type(s)

Publications

Trial Locations

All sites in which the trial HCRN-GU16-260 being conducted in.